Dr. DeGroote is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3885 Upham St
Ste 200
Wheat Ridge, CO 80033Phone+1 303-425-9245Fax+1 303-425-1378
Education & Training
University of ColoradoFellowship, Infectious Disease, 1992 - 1996- University of ColoradoResidency, Internal Medicine, 1988 - 1992
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1988
Certifications & Licensure
CO State Medical License 1991 - 2025- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 5 citationsMycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples.Rebecca M. Davidson, Mary Ann DeGroote, Jamie L. Marola, Sarah N. Buss, Victoria Jones
International Journal of Systematic and Evolutionary Microbiology. 2017-08-15 - 236 citationsAzithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infectionMaurizio Renna, Catherine Schaffner, Karen Brown, Shaobin Shang, Marcela Henao Tamayo
The Journal of Clinical Investigation. 2011-09-01 - 154 citationsComprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosisScott G. Franzblau, Mary Ann DeGroote, Sang-Hyun Cho, Koen Andries, Eric L. Nuermberger
Tuberculosis. 2012-11-01
Press Mentions
Crestone Awarded Funding by Cystic Fibrosis Foundation to Develop Antibiotic That Fights NTM InfectionsJanuary 24th, 2020
Crestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of Novel Antibiotic to Treat NTM InfectionsJanuary 13th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
